Pulmonologists, respiratory specialists, primary care physicians, nurse practitioners, nurses, physician assistants, pharmacists, and other allied healthcare professionals involved in the screening and treatment of patients with COPD.
The goal of this program is to provide new information based on breaking medical news, new data presented at medical meetings, and interactive cases on the most up-to-date evidence-based medicine and clinical trial results in COPD.
Learning Objective (s)
- Describe the natural history of chronic obstructive pulmonary disease (COPD), the importance of early diagnosis of this condition, and recent advances in our understanding of pathophysiologic mechanisms that may serve as targets of therapy.
- Evaluate criteria that have been developed to assess treatment response in COPD, delineate how these criteria can be used to risk-stratify patients in clinical practice, and consider therapeutic treatment options that improve patient outcomes.
CME Information: Physicians
Statement of Accreditation
Projects In Knowledge® is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Projects In Knowledge® designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
To obtain credit:
- Read or listen to each activity carefully.
- Complete/submit each posttest and evaluation.
- Instantly access and print out your certificate.
There is no fee for this activity.
Projects In Knowledge has developed the contract to demonstrate our commitment to providing the highest quality professional education to clinicians, and to help clinicians set educational goals to challenge and enhance their learning experience.
For more information on the contract, click here.
The Disclosure Policy of Projects In Knowledge® requires that all those who have control of content comply with the Standards for Commercial Support. Faculty, planners, PIK editorial scientific team, reviewers, and medical writers are required to disclose any personal interest or relationship they or their spouse/partner have with the supporters of this activity or any commercial interest that is discussed in their presentation. Any discussions of unlabeled/unapproved uses of drugs or devices will also be disclosed during the presentations.
Barry J. Make, MD has received consulting fees from AstraZeneca, Boehringer Ingelheim, Forest Pharmaceuticals, MedImmune, LLC, Merck & Co Inc, Novartis Pharmaceuticals Corporation, and Sunovian Pharmaceuticals Inc; fees for non-CME/CE services from Boehringer Ingelheim, Forest Pharmaceuticals, GlaxoSmithKline, and Pfizer Inc; and conducted contracted research for Actelion Pharmaceuticals Ltd, Boehringer Ingelheim, Forest Pharmaceuticals, GlaxoSmithKline, NABI Biopharmaceuticals, and Sunovian Pharmaceuticals Inc. Dr. Make has disclosed that his presentation will reference the unlabeled/unapproved use of azithromycin.
Sidney S. Braman, MD has received honoraria from Covidien, part of Medtronic Minimally Invasive Therapies Group, and Genentech, a member of the Roche Group; and has received consulting fees from AstraZeneca and Sunovion Pharmaceuticals Inc.
Peer Reviewer has disclosed no relevant relationships.
Projects In Knowledge's staff members have no relevant relationships to disclose.
These activities may contain discussions of unlabeled/unapproved uses of drugs or devices. Specific product disclosure will be forthcoming in each activity.
The opinions expressed in these activities are those of the faculty and do not necessarily reflect those of Projects In Knowledge.
This activity is provided solely as an educational service. Specific patient care decisions are the responsibility of the clinician caring for the patient.
Projects In Knowledge is a registered trademark of Projects In Knowledge, Inc.